CytomX Therapeutics, Inc. ( CTMX) - Stock Earnings
CTMX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -26.5 million USD | 663000 USD |
| 2026Q1 | -18.2 million USD | 10.3 million USD |
| 2026Q2 | -20.7 million USD | 1.4 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
CTMX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -569000 USD | 101.2 million USD |
| 2024 | 31.9 million USD | 138.1 million USD |
| 2025 | -17.4 million USD | 76.2 million USD |
| 2026 Est. | — | — |
CTMX
Price: $3.36
52 week price:
Earnings Per Share: -0.57 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 865300
Ebitda: -10.5 millionMarket Capitalization: 760.5 million